Catalyst Biosciences, Inc. Banner Image

Catalyst Biosciences, Inc. has reached its limit for free report views

Work for Catalyst Biosciences, Inc.? Upgrade Your Profile and unlock all your annual reports.

Catalyst Biosciences, Inc.

  • Ticker CBIO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Catalyst Biosciences, Inc. Logo Image
  • 11-50 Employees
  • Based in South San Francisco, California
Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and complement-mediated disorders. Their protease engineering platform includes two late-stage clinical programs in hemophilia; a research program on engineering of subcutaneous (SQ) complement inhibitors; and a partnered preclinical development program with BiogenMore for dry age-related macular degeneration (AMD). The product candidates generated by their protease engineering platform have improved functionality and potency that allow for: SQ administration of recombinant coagulation factors and complement inhibitors; low-dose, high activity gene therapy constructs; and less frequently dosed intravitreal therapeutics.
Catalyst Biosciences, Inc.

Most Recent Annual Report

Catalyst Biosciences, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Report Locked. Catalyst Biosciences, Inc. has reached its limit for free report views.

Older/Archived Annual Reports